c-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer’s Disease

Overview of attention for article published in Frontiers in Pharmacology, January 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news: 1 news outlet
twitter: 3 X users

video: 1 YouTube creator

Citations

dimensions_citation: 328 Dimensions

Readers on

mendeley: 355 Mendeley

Summary News X YouTube Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 6,465 followers.

JNK c-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer’s Disease https://t.co/oueefsd3Bn

11 Aug 2022

Reply Repost Favourite

Ir You really want to know about intermitent fasting, You must know about JNKs (the real FOXOs activator). c-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer’s Disease https://t.co/BfNLkoPH8u

14 Jun 2022

Reply Repost Favourite

c-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer’s Disease: Ramon Yarza, Silvia V... https://t.co/zrSNusBXLY

12 Jan 2016

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.